Active Pharmaceutical Ingredients

Active Pharmaceutical Ingredients (API) Market (Manufacturing Process - Captive and Contract; API Type - Synthetic Chemical and Biological; Drug Type - Branded, Generic, and OTC; Therapeutic Area - Cardiovascular, Metabolic, Neurological, Oncology, Musculoskeletal, and NSAIDs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023

  • Rep Id : TMRGL1690
  • Published On : Apr 2018
  • No. of Pages : 115
  • Category : Pharmaceutical


Chapter 1 Preface 

Chapter 2 Executive Summary 
2.1 Introduction 
2.2 Global Market: Market Snapshot 
2.3 Comparative Analysis: Global Active Pharmaceutical Ingredients Market, by Geography (2015 & 2023) 
2.4 Waterfall Diagram: Global API Market Revenue, by Therapeutic Area, 2015 (US$ Mn) 

Chapter 3 Market Overview 
3.1 Introduction 
3.2 Market Dynamics 
      3.2.1 Drivers 
              3.2.1.1 Increase in healthcare expenditure to drive market growth
              3.2.1.2 Rapidly aging of global population expected to aid growth of the API market 
              3.2.1.3 Increase in Abbreviated New Drug Applications (ANDA) in the recent past to boost the demand for APIs 
      3.2.2 Restraint 
              3.2.2.1 Adverse regulatory policies to be an important restraining factor 
      3.2.3 Opportunity 
              3.2.3.1 Patent Expiry of Major Biological Drugs in the U.S. and EU 
              3.2.3.2 Growth of the healthcare market in Asia-Pacific and rest of the world (RoW) segments 
3.3 Event Impact Analysis 
3.4 Value Chain Analysis
3.5 Porter’s Five Forces Analysis 
3.6 Market Attractiveness Analysis: Global Market, by Geography, 2015 
3.7 Competitive Landscape: Global Market, by Key Players, 2015 (USD Million) 

Chapter 4 By Manufacturing Process 
4.1 Introduction 
4.2 Captive Manufacturing Market Revenue, 2013-2023 (US$ Mn)
4.3 Contract Manufacturing Market Revenue, 2013-2023 (US$ Mn)

Chapter 5 By API Type
5.1 Introduction 
5.2 Synthetic Chemical Market Revenue, 2013-2023 (US$ Mn)
5.3 API Biological API Market Revenue, 2013-2023 (US$ Mn)

Chapter 6 By Drug Type 
6.1 Introduction 
6.2 API Market Revenue for Branded Prescription Drugs, 2013-2023 (US$ Mn)
6.3 API Market Revenue for Generic Prescription Drugs, 2013-2023 (US$ Mn)
6.4 API Market Revenue for OTC Prescription Drugs, 2013-2023 (US$ Mn)

Chapter 7 By Therapeutic Area
7.1 Introduction 
7.2 API Market Revenue for Cardiovascular Disorders Drug, 2013-2023 (US$ Mn)
7.3 API Market for Drugs for Metabolic Disorders, 2013-2023 (US$ Mn)
7.4 API Market for Drugs for Neurological Disorders, 2013-2023 (US$ Mn)
7.5 API Market for Drugs for Oncology, 2013-2023 (US$ Mn)
7.6 API Market for Drugs for Musculoskeletal Disorders, 2013-2023 (US$ Mn) 
7.7 API Market for NSAIDs, 2013-2023 (US$ Mn) 
7.8 API Market for Drugs for Other Therapeutics Uses, 2013-2023 (US$ Mn) 

Chapter 8 By Region  
8.1 Introduction 
8.2 North America API Market Revenue, by Country, 2013-2023 (US$ Mn)
      8.2.1 U.S. API Market Revenue,, 2013–2023, (US$ Mn)
      8.2.2 Canada API Market Revenue, 2013–2023, (US$ Mn)
8.3 Asia-Pacific Market Revenue, by Country, 2013-2023 (US$ Mn)
      8.3.1 China API Market Revenue,, 2013–2023, (US$ Mn)
      8.3.2 Japan API Market Revenue,, 2013–2023, (US$ Mn)
      8.3.3 India API Market Revenue,, 2013–2023, (US$ Mn)
      8.3.4 Rest of Asia-Pacific API Market Revenue,, 2013–2023, (US$ Mn)
8.4 Europe 
      8.4.1 Germany API Market Revenue,, 2013–2023, (US$ Mn)
      8.4.2 U.K. API Market Revenue,, 2013–2023, (US$ Mn)
      8.4.3 Rest of Europe API Market Revenue,, 2013–2023, (US$ Mn)
8.5 Rest of the World 

Chapter 9 Recommendations 
9.1 Enhance manufacturing capacity through acquisitions in targeted geographies 
9.2 Achieve cost leadership in specific API molecules 

Chapter 10 Company Profiles 
10.1 Allergan plc 
10.2 BASF SE
10.3 Boehringer Ingelheim GmbH 
10.4 Cambrex Corporation 
10.5 Dr. Reddy's Laboratories 
10.6 Lonza Group 
10.7 Mylan N.V. 
10.8 Pfizer, Inc. 
10.9 Sandoz (Novartis AG) 
10.10 Teva Pharmaceutical Industries Ltd.
10.11 WuXi AppTec

.